CORC  > 中国医学科学院 北京协和医学院
Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25years: event-triggered analysis of a randomized controlled trial
Zhu, Feng-cai; Hu, Shang-Ying; Hong, Ying; Hu, Yue-Mei; Zhang, Xun; Zhang, Yi-Ju; Pan, Qin-Jing; Zhang, Wen-Hua; Zhao, Fang-Hui; Zhang, Cheng-Fu
2017
卷号6期号:1页码:12-25
关键词Efficacy HPV-16/18 AS04-adjuvanted vaccine human papillomavirus immunogenicity safety
ISSN号2045-7634
DOI10.1002/cam4.869
URL标识查看原文
收录类别SCIE ; PUBMED
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6362538
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Zhu, Feng-cai,Hu, Shang-Ying,Hong, Ying,et al. Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25years: event-triggered analysis of a randomized controlled trial[J],2017,6(1):12-25.
APA Zhu, Feng-cai.,Hu, Shang-Ying.,Hong, Ying.,Hu, Yue-Mei.,Zhang, Xun.,...&Struyf, Frank.(2017).Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25years: event-triggered analysis of a randomized controlled trial.,6(1),12-25.
MLA Zhu, Feng-cai,et al."Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25years: event-triggered analysis of a randomized controlled trial".6.1(2017):12-25.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace